Trial intelligence / Profile preview

Lidocaine Infiltration for Neuroma-Related Neuropathic Pain

NCT02930551Completed

Sponsor
Danish Pain Research Center
Start
Sep 2016
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine in neuropathic pain (2 arms), sponsored by Danish Pain Research Center. Primary endpoints: Spontaneous pain on numerical rating scale at 15 minutes and Evoked pain on numerical rating scale at 15 minutes. Started Sep 2016; status: completed.

02

Drugs

lidocaine
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT02930551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02930551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call